Concepedia

Karin M. Otte

KM

Statistics

Publications

18

Citations

709

H-Index

15

Active since

2005

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Quantitative BioSciences

University of Wisconsin–Madison

United States Military Academy

Karin M. Otte is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in natural sciences, biochemistry, and chemical biology.

Top concepts

Publications per year

2005–2023

18

Publications

18

Discovery and Mechanistic Study of Al<sup>III</sup>-Catalyzed Transamidation of Tertiary Amides

Justin M. Hoerter, Karin M. Otte, Samuel H. Gellman et al. · Journal of the American Chemical Society · 2007 · 130 citations

Mechanism of Al<sup>III</sup>-Catalyzed Transamidation of Unactivated Secondary Carboxamides

Justin M. Hoerter, Karin M. Otte, Samuel H. Gellman et al. · Journal of the American Chemical Society · 2006 · 103 citations

, , +12

Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors

Qinglin Pu, Hongjun Zhang, Liangqin Guo et al. · ACS Medicinal Chemistry Letters · 2020 · 82 citations · Full text

Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy

Hongjun Zhang, K. Liu, Qinglin Pu et al. · ACS Medicinal Chemistry Letters · 2019 · 44 citations · Full text

Design of novel histone deacetylase inhibitors

Phieng Siliphaivanh, Paul E. Harrington, David J. Witter et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 42 citations · Full text

, , +6

1–5 of 18